基于计算机模拟评估有限采血策略用于血友病B患者重组凝血因子IX个体化预防治疗
本研究通过蒙特卡洛模拟生成5000例接受100 IU/kg重组凝血因子IX(rFIX)的浓度-时间曲线,评估11种含1至3个采血点的有限采血策略(LSS)对个体药代动力学参数的预测性能。各LSS对清除率、半衰期、达1%时间和稳态分布容积的平均偏倚较小,最佳预测性能为给药后10分钟至3小时采1个样本、48至56小时采2个样本。研究表明LSS可通过计算机模拟开发和评估,用于血友病B患者rFIX个体化给药。
要点
- 11种LSS的清除率平均偏倚范围为-1.5%至1.4%,半衰期为-4.5%至-0.7%。
- 达1%时间平均偏倚范围为-2.9%至0%,稳态分布容积为-3.7%至0.3%。
- 最佳预测性能为10分钟至3小时采1个样本、48至56小时采2个样本。
核心结论
- 本研究表明,用于血友病B患者rFIX个体化给药的有限采血策略可通过计算机模拟进行开发和评估。
研究设计与样本
- 研究采用蒙特卡洛模拟,利用文献中rFIX的群体药代动力学参数生成5000例受试者的浓度-时间曲线。
- 在给予100 IU/kg rFIX后80小时区间内,开发了11种含1、2或3个采血点的有限采血策略。
- 采用贝叶斯分析估计每例模拟个体的清除率、半衰期、达1%时间和稳态分布容积。
主要发现
- 各LSS对清除率的平均偏倚范围为-1.5%至1.4%,对半衰期为-4.5%至-0.7%。
- 各LSS对达1%时间的平均偏倚范围为-2.9%至0%,对稳态分布容积为-3.7%至0.3%。
- 上述参数的不精确度范围分别为6.4%至11.9%、10.3%至15.6%、7.3%至10.9%和9%至20.1%。
- 最佳预测性能为给药后10分钟至3小时采1个样本、48至56小时采2个样本。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Individual pharmacokinetic (PK) parameters can be obtained by limited sampling strategies (LSSs). Following 100 IU kg-1 rFIX, LSSs with 1 to 3 samples were evaluated in 5000 simulated subjects. For all LSSs, estimated individual PK parameters showed acceptable bias and precision. One sample between 10 min-3 h and two between 48 h-56 h showed best predictive performance. SUMMARY: Background Patients with severe hemophilia B regularly administer prophylactic intravenous doses of clotting factor IX concentrate to maintain a trough level of at least 0.01 IU mL-1 in order to prevent joint bleeds. Assessment of individual pharmacokinetic (PK) parameters allows individualization of the recombinant factor IX (rFIX) dose. Aim To evaluate the predictive performance of limited sampling strategies (LSSs) with one to three samples to estimate individual PK parameters of rFIX. Methods Monte Carlo simulations were performed to obtain 5000 concentration-time profiles by the use of population PK parameters for rFIX from literature. Eleven LSSs were developed with one, two or three samples taken within an 80-h interval following administration of 100 IU kg-1 rFIX. Clearance (CL), half-life (t1/2 ), time to 1% and steady-state distribution volume (Vss ) were estimated for each simulated individual by the use of Bayesian analysis. Results For each LSS, average bias was small for CL (range - 1.5% to 1.4%), t1/2 (range - 4.5% to - 0.7%), time to 1% (range - 2.9% to 0%), and Vss (range - 3.7% to 0.3%). Imprecision for these parameters ranged from 6.4% to 11.9%, from 10.3% to 15.6%, from 7.3% to 10.9%, and from 9% to 20.1%, respectively. The best predictive performance was achieved with one sample taken between 10 min and 3 h and two samples taken between 48 h and 56 h after administration of rFIX. Conclusions This study demonstrates that limited sampling strategies, used for individualized dosing of rFIX in hemophilia B patients, can be developed and evaluated by in silico simulation.
引用
- Preijers T, Hazendonk HCAM, Fijnvandraat K, et al. In silico evaluation of limited blood sampling strategies for individualized recombinant factor IX prophylaxis in hemophilia B patients. J Thromb Haemost. 2017. PMID: 28688133. doi:10.1111/jth.13771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。